This cluster is too small relative to market cap to warrant a directional trade. Monitor for any material corporate events (earnings, FDA decisions, M&A) that could explain director selling, but treat this as routine portfolio diversification.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 8 $124.89entry
- T+1 · 5mo ago +4.19%α +4.48% · $130.12
- T+5 · 5mo ago +3.95%α +1.84% · $129.82
- T+20 · 4mo ago +35.17%α +33.54% · $168.82
- T+60 · 3mo ago +30.96%α +27.91% · $163.55
Price Chart
How similar events traded
Executive Summary
Three Guardant Health directors sold a total of $1.81M in open-market sales over a 7-day window, with the largest sale ($1.23M) by Director Krognes at $132.51. The cluster is dominated by sales, but the total value is only ~0.01% of the $17.6B market cap, making it trivial in proportion. Non-cash derivative exercises by Joyce and Krognes have zero economic impact.
Key Financial Metrics
Key Facts
- Three directors sold shares totaling $1.81M in open-market transactions over 7 days
- Largest sale: Director Krognes sold 9,294 shares at $132.51 for $1.23M on June 4
- Total sales represent ~0.01% of Guardant Health's $17.6B market cap
- Two directors also had non-cash derivative exercises ($0 economic value)
- No C-suite executives participated in the cluster
Financial Impact
Total open-market sales of $1.81M, representing ~0.01% of market cap, trivial
Risk Factors
- Director sales could accelerate if stock continues to appreciate
- No C-suite participation reduces signal quality
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-GH-1780703457000 |
Track record
38 reports on GH
3 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +22.49% at T+60 after the May 27, 2026 report. 4 of 7 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $145.04 Now $144.03 −0.70% settles Dec 16
- Nov 12, 20264d ago 3 Neutral 1/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $150.87 Now $144.03 −4.53% settles Dec 7
- Nov 5, 202611d ago SC 13G Neutral 3/10 Entry $153.43 Now $144.03 −6.13% settles Dec 4
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $168.58 Now $144.03 −14.56% settles Dec 3
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $175.00 Now $144.03 −17.70% settles Dec 2
- Oct 21, 202626d ago Institutional Cluster Neutral 3/10 Entry $162.94 Now $144.03 −11.61% settles Nov 19
- Oct 14, 20264w ago 144 Neutral 2/10 Entry $165.88 to $154.86 Now $144.03 −13.17% ▼ −6.64% −4.74% vs SPY
- Sep 17, 20268w ago Insider Cluster Bearish 5/10 Entry $179.38 to $158.60 Now $144.03 +19.71% ▲ +11.58% +11.79% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers